A Peer to Peer Research Atmosphere Designed to Encourage and Stimulate Product Research While Maximizing Cost Efficiency
CYGNOS Biotech is conducting multiple clinical studies, including pilot and pivotal trials, in order to support safety and bio-efficacy for several viral disease indications for dogs, cats, and horses to meet FDA New Animal Drug guidance requirements. The Company is also seeking investigators to participate in clinical studies to treat canine malignant melanoma.
Pilot Studies Are Ongoing
- Canine Distemper Pilot Studies
- Feline Upper Respiratory Disease
- Stage II and Stage III Oral Canine Malignant Melanoma Pilot Studies
If you have an interest in seeking further information or in participating in these clinical studies or trials, please contact us.
